Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Male and Female Reproductive Disorders
How do you approach occasional menstrual spotting in transgender men on stable and adequate testosterone therapy ?
Related Questions
Can estradiol patches be prescribed once weekly instead of twice weekly for the treatment of postmenopausal symptoms?
What patient profiles or clinical contexts would justify the initiation of elinzanetant (Lynkuet) for postmenopausal vasomotor symptoms, considering its mechanism and current evidence base?
What are the current guidelines for hormone therapy in perimenopausal women, specifically regarding the use of estrogen, progesterone, and possibly testosterone ?
Have any studies shown that testosterone replacement therapy lowers the incidence of prostate cancer in hypogonadal men, or is the evidence still largely neutral?
How should we approach the management of PCOS in transgender men seeking virilization?
What is the strength of evidence supporting intranasal testosterone use for preserving fertility in hypogonadal men.
In an obese male with low testosterone, would you initiate testosterone replacement therapy at the initial visit, or start tirzepatide first and monitor for improvement in testosterone levels and erectile function?
Is abnormally elevated estradiol an expected finding in patients with PCOS?
In patients with hypogonadism, when do you recommend subcutaneous over intramuscular testosterone injections?
What estradiol patch dose do you recommend for transgender adult patients with prior history of stroke or myocardial infarction?
